{
    "organizations": [],
    "uuid": "9009de31e32a6fdc53a2d04321d316acb40d6eb8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-aldeyra-therapeutics-announces-fir/brief-aldeyra-therapeutics-announces-first-patient-enrolled-in-allergic-conjunctivitis-phase-3-clinical-trial-idUSASC09X10",
    "ord_in_thread": 0,
    "title": "BRIEF-Aldeyra Therapeutics Announces First Patient Enrolled In Allergic Conjunctivitis Phase 3 Clinical Trial",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " Aldeyra Therapeutics Inc:\n* ALDEYRA THERAPEUTICS ANNOUNCES FIRST PATIENT ENROLLED IN ALLERGIC CONJUNCTIVITIS PHASE 3 CLINICAL TRIAL\n* ALDEYRA THERAPEUTICS INC - ENROLLED FIRST PATIENT IN A PHASE 3 CLINICAL TRIAL OF TOPICAL OCULAR REPROXALAP FOR TREATMENT OF ALLERGIC CONJUNCTIVITIS\n* ALDEYRA THERAPEUTICS INC - LOOK FORWARD TO PRESENTING RESULTS OF ALLERGIC CONJUNCTIVITIS PHASE 3 CLINICAL TRIAL IN SECOND HALF OF 2018 OR EARLY 2019 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-24T20:07:00.000+03:00",
    "crawled": "2018-04-25T14:13:59.020+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "aldeyra",
        "therapeutic",
        "inc",
        "aldeyra",
        "therapeutic",
        "announces",
        "first",
        "patient",
        "enrolled",
        "allergic",
        "conjunctivitis",
        "phase",
        "clinical",
        "trial",
        "aldeyra",
        "therapeutic",
        "inc",
        "enrolled",
        "first",
        "patient",
        "phase",
        "clinical",
        "trial",
        "topical",
        "ocular",
        "reproxalap",
        "treatment",
        "allergic",
        "conjunctivitis",
        "aldeyra",
        "therapeutic",
        "inc",
        "look",
        "forward",
        "presenting",
        "result",
        "allergic",
        "conjunctivitis",
        "phase",
        "clinical",
        "trial",
        "second",
        "half",
        "early",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}